HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial
HIP ATTACK
1 other identifier
interventional
3,001
17 countries
69
Brief Summary
HIP ATTACK is an international randomized controlled trial of 3000 patients with a hip fracture that requires a surgical intervention. This trial will determine the effect of accelerated medical clearance and accelerated surgery compared to standard care on the 90-day risk of mortality and major perioperative complication (i.e., a composite of mortality, nonfatal myocardial infarction, nonfatal pulmonary embolism, nonfatal pneumonia, nonfatal sepsis, nonfatal stroke, and nonfatal life-threatening and major bleeding).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2014
Longer than P75 for not_applicable
69 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2014
CompletedFirst Posted
Study publicly available on registry
January 6, 2014
CompletedStudy Start
First participant enrolled
March 14, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 24, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedJanuary 22, 2024
January 1, 2024
5.4 years
January 2, 2014
January 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Composite - major perioperative complication
Composite of mortality, nonfatal myocardial infarction, nonfatal pulmonary embolism, nonfatal pneumonia, nonfatal sepsis, nonfatal stroke, and nonfatal life-threatening and major bleeding
90 days
Mortality
All-cause mortality
90 days
Secondary Outcomes (40)
All-cause mortality
90 days and 1 year
Vascular mortality
90 days and 1 year
Non-vascular mortality
90 days and 1 year
Myocardial infarction
90 days and 1 year
Cardiac revascularization procedure
90 days and 1 year
- +35 more secondary outcomes
Study Arms (2)
Accelerated medical clearance and surgery
EXPERIMENTALRapid medical clearance with targeted arrival to the operating room within 6 hours of diagnosis of a hip fracture requiring surgical repair.
Standard surgical care
NO INTERVENTIONSurgical hip fracture repair according to the standard timing.
Interventions
Rapid medical clearance with targeted arrival to the operating room within 6 hours of diagnosis of a hip fracture requiring surgical repair.
Eligibility Criteria
You may qualify if:
- age ≥45 years; and
- diagnosis of hip fracture during working hours with a low-energy mechanism (i.e., falling from standing height) requiring surgery.
You may not qualify if:
- patients requiring emergent surgery or emergent interventions for another reason (e.g., subdural hematoma, abdominal pathology requiring urgent laparotomy, acute limb ischemia, other fractures or trauma requiring emergent surgery, necrotising fasciitis, coronary revascularization, pacemaker-implantation);
- open hip fracture;
- bilateral hip fractures;
- peri-prosthetic fracture;
- therapeutic anticoagulation not induced by a Vitamin K Antagonist, unfractionated heparin, (e.g., administration of therapeutic Low Molecular Weight Heparin (LMWH) (\>6,000 u/24h) in the 24 hours prior to enrolment, or intake of any other non-reversible oral anticoagulant(s) for which there is no reversing agent available
- patients on a therapeutic vitamin K antagonist with a history of heparin induced thrombocytopenia (HIT);
- patients refusing participation; or
- patients previously enrolled in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McMaster Universitylead
- Population Health Research Institutecollaborator
- Hamilton Health Sciences Corporationcollaborator
Study Sites (69)
Regional Medical Center of San Jose
San Jose, California, United States
University of Maryland
Baltimore, Maryland, 20742, United States
Lahey Hospital and Medical Centre
Burlington, Massachusetts, 01805, United States
Tufts Medical Centre
Washington, Massachusetts, 02111, United States
Ohio State University Medical Centre
Columbus, Ohio, 43210, United States
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Cliniques Universitaires Saint-Luc
Woluwe-Saint-Lambert, Belgium
South Health Campus
Calgary, Alberta, Canada
University of Alberta Hospital
Edmonton, Alberta, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
Concordia Hip and Knee Institute
Winnipeg, Manitoba, MB R2K 2M9, Canada
QEII Health Sciences
Halifax, Nova Scotia, B3H 3A7, Canada
Royal Victoria Hospital
Barrie, Ontario, Canada
Etobicoke General Hospital
Etobicoke, Ontario, Canada
St. Joseph's Hospital Hamilton
Hamilton, Ontario, L8N 4A6, Canada
Hamilton Health Sciences - Juravinski Hospital
Hamilton, Ontario, L8V 5C2, Canada
Kingston General Hospital
Kingston, Ontario, K7L 2V7, Canada
Grand River Hospital
Kitchener, Ontario, Canada
Victoria Hospital, London Health Sciences
London, Ontario, Canada
Markham Stouffville Hospital
Markham, Ontario, Canada
Ottawa General Hospital
Ottawa, Ontario, K1H 8L6, Canada
Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, P7B 6V4, Canada
Humber River Hospital
Toronto, Ontario, M3M 0B2, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Beijing Chaoyang Hospital
Beijing, China
Fundacion Cardioinfantil
Bogotá, 13B-60, Colombia
Centre Hospitalier Lyon Sud
Lyon, France
Nimes University Hospital
Nîmes, 30029, France
Queen Mary Hospital
High West, Hong Kong
Government TD Medical College
Alappuzha, 688005, India
Sparsh Hospital
Bangalore, 560099, India
PGIMER
Chandigarh, India
Bangalore Baptist Hospital
Hebbāl, 560024, India
NH Kolkata
Kolkata, 700099, India
CMC Ludhiana
Ludhiana, 141008, India
Seven Star Hospital
Nagpur, India
AIIMS Hospital
New Delhi, India
JIPMER
Puducherry, India
Sancheti Institute for Orthopaedics and Rehabilitation
Shivājīnagar, 411005, India
Government Medical Hospital
Trivandrum, India
Ospedale San Raffaele
Milan, 20132, Italy
Humanitas Research Hospital
Milan, Italy
IRCCS Galeazzi Orthopedic Institute
Milan, Italy
ASST Sette Laghi - Ospedale Di
Varese, Italy
Hospital Pulau Pinang
George Town, Malaysia
University Malaya Medical Centre (UMMC)
Kuala Lumpur, 59100, Malaysia
Deventer Ziekenhuis
Deventer, Netherlands
Shifa International Hospitals
Islamabad, 44000, Pakistan
The Aga Khan University
Karachi, 74800, Pakistan
SPZOZ Szpital Powiatowy w Bochni im M. Wieckiej
Bochnia, Poland
University Hospital & Educational Center of Medical University in Lodz
Lodz, Poland
Samodzielny Publiczny Zakład Opieki Zdrowotnej W Myślenicach
Myślenice, 32-400, Poland
Groote Schuur Hospital
Cape Town, 7925, South Africa
Stellenbosch University
Cape Town, South Africa
Chris Hani Baragwanath Hospital
Johannesburg, 2193, South Africa
Hospital San Pau
Barcelona, 08025, Spain
Hospital Universitaire Vall d'Hebron
Barcelona, 08035, Spain
Corporació Sanitària Parc Taulí
Barcelona, 08208, Spain
Mutua de Terrassa Hospital
Barcelona, 08221, Spain
Hospital Sant Camil (Consorci Sanitari Garraf)
Barcelona, Spain
Costa del Sol
Marbella, 29603, Spain
Hospital Clinico Universitario de Vallad
Valladolid, Spain
Ramathibodi Hospital
Bangkok, 10400, Thailand
Calderdale & Huddersfield NHS
Huddersfield, United Kingdom
Chelsea and Westminster Hospital
London, SW10 9NH, United Kingdom
West Middlesex Hospital
London, United Kingdom
Peterborough City Hospital
Peterborough, United Kingdom
King's Mill Hospital
Sutton in Ashfield, NG17 4JL, United Kingdom
Related Publications (4)
Khan JS, Mulazzani F, Devereaux PJ, Bhandari M, Guerra-Farfan E, Patel A, Shanthanna H, Slobogean G, Sigamani A, Umer M, Feibel RJ, Tiboni ME, Tandon V, Harvey V, Balasubramanian K, Vincent J, Tonelli AC, Gilron I, Torrie AM, Borges FK; HIP ATTACK Investigators. Pain as a Driver of Myocardial Injury in Hip Fracture Patients: A Hip Fracture Accelerated Surgical Treatment and Care Track (HIP ATTACK) Trial Secondary Analysis. Anesthesiology. 2026 Feb 1;144(2):289-300. doi: 10.1097/ALN.0000000000005818. Epub 2025 Oct 27.
PMID: 41147656DERIVEDHIP ATTACK Investigators. Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial. Lancet. 2020 Feb 29;395(10225):698-708. doi: 10.1016/S0140-6736(20)30058-1. Epub 2020 Feb 9.
PMID: 32050090DERIVEDBorges FK, Devereaux PJ, Cuerden M, Bhandari M, Guerra-Farfan E, Patel A, Sigamani A, Umer M, Neary J, Tiboni M, Tandon V, Ramokgopa MT, Sancheti P, John B, Lawendy A, Balaguer-Castro M, Jenkinson R, Sleczka P, Nabi Nur A, Wood GCA, Feibel R, McMahon JS, Sigamani A, Biccard BM, Landoni G, Szczeklik W, Wang CY, Tomas-Hernandez J, Abraham V, Vincent J, Harvey V, Pettit S, Sontrop J, Garg AX; HIP ATTACK investigators. Effects of accelerated versus standard care surgery on the risk of acute kidney injury in patients with a hip fracture: a substudy protocol of the hip fracture Accelerated surgical TreaTment And Care tracK (HIP ATTACK) international randomised controlled trial. BMJ Open. 2019 Sep 24;9(9):e033150. doi: 10.1136/bmjopen-2019-033150.
PMID: 31551393DERIVEDBorges FK, Bhandari M, Patel A, Avram V, Guerra-Farfan E, Sigamani A, Umer M, Tiboni M, Adili A, Neary J, Tandon V, Sancheti PK, Lawendy A, Jenkinson R, Ramokgopa M, Biccard BM, Szczeklik W, Wang CY, Landoni G, Forget P, Popova E, Wood G, Nabi Nur A, John B, Sleczka P, Feibel RJ, Balaguer-Castro M, Deheshi B, Winemaker M, de Beer J, Kolesar R, Teixidor-Serra J, Tomas-Hernandez J, McGillion M, Shanthanna H, Moppett I, Vincent J, Pettit S, Harvey V, Gauthier L, Alvarado K, Devereaux PJ. Rationale and design of the HIP fracture Accelerated surgical TreaTment And Care tracK (HIP ATTACK) Trial: a protocol for an international randomised controlled trial evaluating early surgery for hip fracture patients. BMJ Open. 2019 May 1;9(4):e028537. doi: 10.1136/bmjopen-2018-028537.
PMID: 31048449DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philip J Devereaux, MD, PhD
McMaster University
- PRINCIPAL INVESTIGATOR
Mohit Bhandari, MD, PhD
McMaster University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2014
First Posted
January 6, 2014
Study Start
March 14, 2014
Primary Completion
August 24, 2019
Study Completion
September 30, 2022
Last Updated
January 22, 2024
Record last verified: 2024-01